Cambridge Investment Research Advisors’s ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 UCIB Stock Holding History
Bought
Maintained
Sold
Other funds holding UCIB
LWAM
RF
BGAI
Cambridge Investment Research Advisors's UCIB Position: Q4 2024 in Review
Cambridge Investment Research Advisors sold out of ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 (UCIB) in Q4 2024, closing a stake of 24,120 shares — an estimated $627K sold.
Cambridge Investment Research Advisors first reported a position in UCIB in Q2 2021 and held it in 12 quarters. The position peaked at $1.35M in Q2 2021. 9 funds tracked by Wall St. Rank hold UCIB as of Q4 2024.
- Cambridge Investment Research Advisors reported no remaining ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 position as of Q4 2024 after selling out during the quarter.
- Cambridge Investment Research Advisors sold 24,120 ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 shares in Q4 2024, an estimated $627K.
- Cambridge Investment Research Advisors first reported a position in ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 in Q2 2021 and held it in 12 quarters.
- Cambridge Investment Research Advisors's ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 position peaked at $1.35M in Q2 2021.
- 9 funds tracked by Wall St. Rank held ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due Apr 5 2038 as of Q4 2024.
Based on Cambridge Investment Research Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.